Diametric Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Diametric Capital’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,517	Closed	-$553K	–	527
2024 Q2	$553K	Sell	13,517 -14,083	-51%	-$586K	0.3%	85
2024 Q1	$1.17M	Buy	27,600 +11,774	+74%	+$495K	0.65%	37
2023 Q4	$671K	Buy	+15,826	New	+$455K	0.41%	74

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Diametric Capital's CERE Position: Q3 2024 in Review

Diametric Capital sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 13,517 shares — an estimated $553K sold.

Diametric Capital first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $1.17M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Diametric Capital reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Diametric Capital sold 13,517 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $553K.
Diametric Capital first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
Diametric Capital's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.17M in Q1 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Diametric Capital's 13F filing for Q3 2024, filed 13 Nov 2024.